{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreifmiduvxq2xwj5tycdybblu5vs7tjgzeqjr4izkwokbzopezikopy",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mnb2mrxrrjq2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreibddscsnr6c7mgnvg4zqgtakkhlfeiinca32y46kzgiispkinrcmu"
    },
    "mimeType": "image/jpeg",
    "size": 73053
  },
  "path": "/2026/06/01/ebola-bundibugyo-vaccine-studies-cepi-62-million-funding/?utm_campaign=rss",
  "publishedAt": "2026-06-01T21:35:53.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Health",
    "In the Lab",
    "global health",
    "infectious disease",
    "public health",
    "Vaccines"
  ],
  "textContent": "With no licensed vaccines available to protect against the Ebola virus currently spreading in the Congo, efforts are underway to fast-track development of at least three vaccines.",
  "title": "STAT+: Global coalition to fast-track three vaccines targeting Ebola outbreak with $62 million in funding",
  "updatedAt": "2026-06-01T21:45:32.000Z"
}